Investigators studied apixaban pharmacokinetics, pharmacodynamics, and hemorrhage risk by kidney function. Kidney function is a major predictor of hemorrhage among patients with atrial fibrillation ...

AstraZeneca's anticoagulant reversal agent Andexxa was given an accelerated approval by the FDA in 2018, but the company's plan to get that upgraded to a full approval is facing some pushback.

Abstract and Introduction Abstract. Purpose The pharmacology, pharmacokinetics, efficacy, and safety of apixaban are reviewed. Summary Apixaban is an oral, direct, selective factor Xa inhibitor with a ...

Apixaban 5 mg orally twice daily (2.5 mg twice daily in selected patients) ... news Mixed Results for Factor Xa Reversal Agent in Intracerebral Hemorrhage: ANNEXA-I; ...

Apixaban is currently indicated in Europe for the prevention of VTE in patients who have undergone total knee replacement or total hip replacement. Apixaban is also being investigated in Phase III ...

Following court ordered reversal, Reading School District receives $51 million for STEM school construction completion. Caitlin Rearden. Caitlin Rearden. Reporter. Author facebook; ...

Eliquis is among the drugs subject to the first round of Medicare negotiations under the Inflation Reduction Act, which resulted in a 56% cut on its list price. Image. Phil Taylor.